(Total Views: 81)
Posted On: 01/21/2020 2:05:41 PM
Post# of 21237

$RFL News Article - Rafael Pharmaceuticals Announces the Initiation of a Phase 1b/2 Clinical Trial of CPI-613 (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer https://marketwirenews.com/news-releases/rafa...66564.html


My Twitter: WhyteStocks